PSY18 COST-EFFECTIVENESS OF TOFACITINIB IN ACTIVE PSORIATIC ARTHRITIS AFTER ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) FAILURE OR INTOLERANCE IN SPAIN
Abstract
Authors
J.D. Cañete M. Vázquez J. Nicolas F. Rebollo S. Gómez A. López C. Gari C. Peral